The Berlin Charité has treated a 19-year-old patient with Crispr technology for the first time in Germany, making him no longer dependent on blood transfusions and regenerating his immune system. #Crispr #Gentherapie #BetaThalassämie (translated)

The Berlin Charité has treated a 19-year-old patient with Crispr technology for the first time in Germany, making him no longer dependent on blood transfusions and regenerating his immune system. #Crispr #Gentherapie #BetaThalassämie (translated)
